(Q48606111)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hiroaki Hori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

M Ota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M Ishikawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

N Sato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

D Sasayama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

K Hattori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

T Teraishi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Y Nakata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

20 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

72-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Glutamate-mediated glial injury: mechanisms and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

White matter alterations in deficit schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Development, disease and degeneration in schizophrenia: a unitary pathophysiological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

10-year trends in the treatment and outcomes of patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

1H-MRS at 4 tesla in minimally treated early schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01853.X

10.1111/J.1600-0447.2012.01853.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22432602%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference